ArticleOncoTargets and therapy2022

Clinical Impact of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Associated

Ying-Shan Chung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.